Utilization of evidence-based therapies for heart failure in the institutionalized elderly

European Journal of Heart Failure

Volumn 7, Issue 7, 2005, Pages 1122-1125

  Shibata, Marcelo C ^a   Soneff, Cynthia M ^a   Tsuyuki, Ross T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Elderly; Heart failure; Nursing home; Treatment

Indexed keywords

ANGIOTENSIN II ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOOXYGENASE 2 INHIBITOR; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; INFLUENZA VACCINE; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; PNEUMOCOCCUS VACCINE; SODIUM; SPIRONOLACTONE;

AGE; AGED; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DATA BASE; DRUG USE; EVIDENCE BASED MEDICINE; FEMALE; GENDER; HEALTH CARE UTILIZATION; HEART FAILURE; HUMAN; INFLUENZA VACCINATION; INSTITUTIONALIZATION; LIQUID; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PATIENT MONITORING; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SODIUM RESTRICTION;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIURETICS; DRUG UTILIZATION; EVIDENCE-BASED MEDICINE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INSTITUTIONALIZATION; MALE; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES;

EID: 28344442365     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.03.005     Document Type: Article

References (13)

1. R.T. Tsuyuki, M.C. Shibata, C. Nilsson, and M. Hervas-Malo Contemporary burden of illness of congestive heart failure in Canada Can J Cardiol 19 2003 436 438
2. American Heart Association 2002 Heart and stroke statistical update 2001 American Heart Association
3. K.K. Ho, K.M. Anderson, W.B. Kannel, W. Grossman, and D. Levy Survival after the onset of congestive heart failure in Framingham Heart Study subjects Circulation 88 1993 107 115
4. M.R. Cowie, D.A. Wood, S.G. Thompson, P.A. Poole-Wilson, and V. Suresh Incidence and aetiology of heart failure. A population-based study Eur Heart J 20 1999 421 428
5. M.D. Flather, S. Yusuf, and L. Kober Long term ACE-inhibitor therapy in patients with heart failure or left ventricular dysfunction: a systematic overview of data from individual patients Lancet 355 2000 1575 1581
6. EUROASPIRE I and II Group Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries Lancet 357 2001 995 1001
7. R. Garg, and S. Yusuf Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure JAMA 273 1995 1450 1456
8. The Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
9. B. Pitt, F. Zannad, and W. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
10. A.G. Bertoni, V. Duren-Winfield, and W.T. Ambrosius Quality of heart failure care in managed Medicare and Medicaid patients in North Carolina Am J Cardiol 93 2004 714 718
11. G. Gambassi, D.E. Forman, and K.L. Lapane Management of heart failure among very old persons living in long-term care: has the voice of trials spread? The SAGE study group Am Heart J 139 2000 85 93
12. M.D. Flather, M.C. Shibata, and A.J. Coats Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS Investigators) Eur Heart J 26 2005 215 225 [Epub 2005 Jan. 9]
13. J.G.F. Cleland, M. Tendera, and J. Adamus Perindopril for elderly people with chronic heart failure. The PEP-CHF study. The PEP-CHF investigators Eur J Heart Fail 3 1999 211 217